|
1
|
Otsuji E, Kuriu Y, Okamoto K, et al:
Outcome of surgical treatment for patients with scirrhous carcinoma
of the stomach. Am J Surg. 188:327–332. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ikeguchi M, Miyake T, Matsunaga T, et al:
Recent results of therapy for scirrhous gastric cancer. Surg Today.
39:290–294. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yashiro M and Hirakawa K: Cancer-stromal
interactions in scirrhous gastric carcinoma. Cancer Microenviron.
3:127–135. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yamamoto M, Sumiyoshi H, Nakagami K,
Taniyama K and Tahara E: Distribution of collagen types I and III
and basal lamina in human gastric carcinoma: an immunohistochemical
and electron microscopic study. Virchows Arch A Pathol Anat
Histopathol. 403:313–322. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yoshida K, Yokozaki H, Niimoto M, Ito H,
Ito M and Tahara E: Expression of TGF-β and procollagen type I and
type III in human gastric carcinomas. Int J Cancer. 44:394–398.
1989.
|
|
6
|
Jain RK: Barriers to drug delivery in
solid tumors. Sci Am. 271:58–65. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Heldin CH, Rubin K, Pietras K and Ostman
A: High interstitial fluid pressure - an obstacle in cancer
therapy. Nat Rev Cancer. 4:806–813. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nakajima TE, Yanagihara K, Takigahira M,
et al: Antitumor effect of SN-38-releasing polymeric micelles,
NK012, on spontaneous peritoneal metastases from orthotopic gastric
cancer in mice compared with irinotecan. Cancer Res. 68:9318–9322.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Worthley DL, Giraud AS and Wang TC: The
extracellular matrix in digestive cancer. Cancer Microenviron.
3:177–185. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Naito Y, Sakamoto N, Oue N, et al:
MicroRNA-143 regulates collagen type III expression in stromal
fibroblasts of scirrhous type gastric cancer. Cancer Sci.
105:228–235. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cordes KR, Sheehy NT, White MP, et al:
miR-145 and miR-143 regulate smooth muscle cell fate and
plasticity. Nature. 460:705–710. 2009.PubMed/NCBI
|
|
15
|
Iio A, Nakagawa Y, Hirata I, Naoe T and
Akao Y: Identification of non-coding RNAs embracing
microRNA-143/145 cluster. Mol Cancer. 9:1362010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Long X and Miano JM: Transforming growth
factor-β1 (TGF-β1) utilized distinct pathways for the
transcriptional activation of microRNA 143/145 in human coronary
artery smooth muscle cells. J Biol Chem. 286:30119–30129. 2011.
|
|
17
|
Ochiai A, Yasui W, Kameda T, Takanashi A,
Takekura N and Tahara E: The effect of phorbol esters on cell
growth and epidermal growth factor receptor modulation in a human
gastric carcinoma cell line TMK-1. Hiroshima J Med Sci. 38:191–195.
1989.PubMed/NCBI
|
|
18
|
Yanagihara K, Seyama T, Tsumuraya M,
Kamada N and Yokoro K: Establishment and characterization of human
signet ring cell gastric carcinoma cell lines with amplification of
the c-myc oncogene. Cancer Res. 51:381–386. 1991.PubMed/NCBI
|
|
19
|
Yanagihara K, Tanaka H, Takigahira M, et
al: Establishment of two cell lines from human gastric scirrhous
carcinoma that possess the potential to metastasize spontaneously
in nude mice. Cancer Sci. 95:575–582. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fuyuhiro Y, Yashiro M, Noda S, et al:
Cancer-associated orthotopic myofibroblasts stimulates the motility
of gastric carcinoma cells. Cancer Sci. 103:797–805. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Naito Y, Oue N, Hinoi T, et al: Reg IV is
a direct target of intestinal transcriptional factor CDX2 in
gastric cancer. PLoS One. 7:e475452012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kondo T, Oue N, Yoshida K, et al:
Expression of POT1 is associated with tumor stage and
telomere length in gastric carcinoma. Cancer Res. 64:523–529.
2004.
|
|
23
|
Shinmei S, Sakamoto N, Goto K, et al:
MicroRNA-155 is a predictive marker for survival in patients with
clear cell renal cell carcinoma. Int J Urol. 20:468–477. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yasui W, Ayhan A, Kitadai Y, et al:
Increased expression of p34cdc2 and its kinase activity in human
gastric and colonic carcinomas. Int J Cancer. 53:36–41. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ueda T, Volinia S, Okumura H, et al:
Relation between microRNA expression and progression and prognosis
of gastric cancer: a microRNA expression analysis. Lancet Oncol.
11:136–146. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu L, Chen Q, Lai R, et al: Elevated
expression of mature miR-21 and miR-155 in cancerous gastric
tissues from Chinese patients with gastric cancer. J Biomed Res.
24:187–197. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gao P, Xing AX, Zhou GY, et al: The
molecular mechanism of microRNA-145 to suppress invasion-metastasis
cascade in gastric cancer. Oncogene. 32:491–501. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zheng L, Pu J, Qi T, et al: miRNA-145
targets v-ets erythroblastosis virus E26 oncogene homolog 1 to
suppress the invasion, metastasis, and angiogenesis of gastric
cancer cells. Mol Cancer Res. 11:182–193. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ostenfeid MS, Bramsen JB, Lamy P, et al:
miR-145 induces caspase-dependent and -independent cell death in
urothelial cancer cell lines with targeting of an expression
signature present in Ta bladder tumors. Oncogene. 29:1073–1084.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hamano R, Miyata H, Yamasaki M, et al:
Overexpression of miR-200c induces chemoresistance in esophageal
cancers mediated through activation of the akt signaling pathway.
Clin Cancer Res. 17:3029–3038. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Villadsen SB, Bramsen JB, Ostenfeld MS, et
al: The miR-143/−145 cluster regulates plasminogen activator
inhibitor-1 in bladder cancer. Br J Cancer. 106:366–374. 2012.
|
|
32
|
Kalluri R and Zeisberg M: Fibroblasts in
cancer. Nat Rev Cancer. 6:392–401. 2006. View Article : Google Scholar
|
|
33
|
Yang S, Cui H, Xie N, et al: miR-145
regulates myofibroblast differentiation and lung fibrosis. FASEB J.
27:2382–2391. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mahara K, Kato J, Terui T, et al:
Transforming growth factor beta 1 secreted from scirrhous gastric
cancer cells is associated with excess collagen deposition in the
tissue. Br J Cancer. 69:777–783. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kawajiri H, Yashiro M, Shinto O, et al: A
novel transforming growth factor β receptor kinase inhibitor, A-77,
prevents the peritoneal dissemination of scirrhous gastric
carcinoma. Clin Cancer Res. 14:2850–2860. 2008.
|
|
36
|
Shinto O, Yashiro M, Kawajiri H, et al:
Inhibitory effect of a TGFβ receptor type-I inhibitor,
Ki26894, on invasiveness of scirrhous gastric cancer cells. Br J
Cancer. 102:844–851. 2010.
|
